SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 34 filers reported holding SINOVAC BIOTECH LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,243,000 | +12.6% | 1,091,500 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $5,545,000 | -3.2% | 1,091,500 | 0.0% | 0.02% | +5.6% |
| Q2 2015 | $5,730,000 | +5.8% | 1,091,500 | 0.0% | 0.02% | +5.9% |
| Q1 2015 | $5,414,000 | -2.8% | 1,091,500 | +2.5% | 0.02% | -10.5% |
| Q4 2014 | $5,572,000 | +22.0% | 1,065,301 | +12.2% | 0.02% | +5.6% |
| Q3 2014 | $4,566,000 | -14.7% | 949,300 | 0.0% | 0.02% | -10.0% |
| Q2 2014 | $5,354,000 | -30.5% | 949,300 | -11.2% | 0.02% | -28.6% |
| Q1 2014 | $7,700,000 | +17.6% | 1,069,500 | 0.0% | 0.03% | +7.7% |
| Q4 2013 | $6,545,000 | +2.3% | 1,069,500 | 0.0% | 0.03% | -16.1% |
| Q3 2013 | $6,396,000 | +52.2% | 1,069,500 | 0.0% | 0.03% | +29.2% |
| Q2 2013 | $4,203,000 | – | 1,069,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |